{"id":20787,"date":"2024-05-06T16:39:57","date_gmt":"2024-05-06T11:09:57","guid":{"rendered":"https:\/\/www.moneyworks4me.com\/investmentshastra\/?p=20787"},"modified":"2024-05-06T17:37:32","modified_gmt":"2024-05-06T12:07:32","slug":"indegene-ipo-review","status":"publish","type":"post","link":"https:\/\/www.moneyworks4me.com\/investmentshastra\/indegene-ipo-review\/","title":{"rendered":"Indegene IPO Review"},"content":{"rendered":"
\n

Indegene Limited IPO Details:<\/strong><\/h2>\n

Opening Date:<\/strong> May 06, 2024
\nClosing Date:<\/strong> May 08, 2024
\nListing:<\/strong> BSE and NSE
\nNumber of Shares:<\/strong> 40,746,891 shares
\nFace Value:<\/strong> Rs 2 per share
\nPrice Band:<\/strong> Rs 430-452 per equity share
\nIssue Size:<\/strong> Rs 1841.76 crore
\nRecommendation: Subscribe for listing gains<\/strong><\/p>\n<\/div>\n

About the Indegene Limited Company:<\/strong><\/h2>\n

Indegene Ltd<\/a> provides commercialization and digital services to its clients in the life sciences field, which includes biopharmaceuticals, biotech, and medical devices. Much like BPO (business process outsourcing) companies work, Indegene provides range of products assisting in drug development, clinical trials, and all the way to marketing and government regulation compliance, supported by technology. It has over 20 years of healthcare experience to empower the full product-market lifecycle. In FY23, it served about 65 active clients and all the top 20 biopharmaceutical firms by revenue, across 10 countries.<\/p>\n

About the industry:<\/u><\/strong><\/h2>\n

The Life sciences industry comprises of entities engaged in R&D, manufacturing and marketing of drugs and medical devices. 2 main segments under this are:<\/p>\n